Key Takeaways Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be ...
The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.
Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.
According to the latest data from the Centers for Disease Control, the current bird flu outbreak has caused 67 human cases of ...
The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.
The companies are developing experimental vaccines against pandemic influenza, including the avian H5N1 strain that has infected more than 60 people in the U.S. in the past year, mostly from ...
TUESDAY, Jan. 21, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services (HHS) is awarding the ...
The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...
Moderna (MRNA) announced ongoing support from the U.S. Department of Health and Human Services, HHS, to accelerate the development of ...
You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to ...
The Centers for Disease Control and Prevention (CDC) said the "U.S. government is developing vaccines against avian influenza A(H5N1) viruses in case they are needed." According to the CDC ...
There is also a lot of uncertainty around the prospects of an avian flu vaccine for humans. Several major companies that manufacture them have said they could expedite the production of millions ...